Products

What will AGI do for Altanserin?

This classification denotes a serotonin antagonist with the molecular formula C22H22FN3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 5015H744JQ chemically known as 3-(2-(4-(p-fluorobenzoyl)piperidino)ethyl)-2-thio-2,4(1h,3h)-quinazolinedione but generally known as altanserin, which bears US NIH Compound Identifier 3033677. European Medicines Agency schedules Altanserin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05375MIG. The term ALTANSERIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24. ). Most nations schedule altanserin under HS 29335995 and SITC 51576. As of Q4 2014, ALTANSERIN remains the US FDA Preferred Term for this commodity. Altanserin bears US NLM identifiers UMLS ID C0102811 and NCI Concept Code C77258. SMILES: C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=S.